Current Edition


Direct-to-Patient Clinical Trials

Dates: August 09-10, 2018 Location: Philadelphia, PA Positive patient experiences lead to successful clinical trials with high adherence and high participation rates. The pharmaceutical industry’s …

Continue Reading →

New England Journal of Medicine publishes two positive Phase 3 trials showing Dupixent® (dupilumab) improved moderate-to-severe asthma

Results showed Dupixent demonstrated a significant improvement in multiple asthma endpoints in two Phase 3 clinical trials in a broad population of patients with uncontrolled …

Continue Reading →